|
Press Releases |
|
 |
|
Tuesday, December 6, 2022 |
|
Global pharma giants partner Singapore researchers to boost innovation in biologics and vaccines manufacturing |
Leading pharma companies GSK, Sanofi and Takeda will partner with research communities from the Agency for Science, Technology and Research (A*STAR); National University of Singapore (NUS); Nanyang Technological University, Singapore (NTU Singapore) and its innovation and enterprise company, NTUitive; and Singapore Institute of Technology (SIT) to boost Singapore's biologics manufacturing capabilities. more info >> |
|
Thursday, June 2, 2022 |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
more info >> |
|
Boehringer Ingelheim Enters Global Licensing Agreement to Develop and Commercialize Innovative Antibodies from A*STAR for Targeted Cancer Therapies |
Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR. more info >> |
|
Thursday, September 30, 2021 |
|
A*STAR and Local SME Work with Vaccination Centres to Deploy AVID System for Filling Syringes |
The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers. more info >> |
|
Friday, July 31, 2020 |
|
Singapore Cancer Drug ETC-159 Advances Further in Clinical Trials |
Made-in-Singapore cancer drug, ETC-159, has achieved a new developmental milestone in achieving "First Patient First Visit[1]" in Phase 1B. The first dose of ETC-159 has been administered to patients in this new phase of clinical testing, which for the first time, will look at efficacy in addition to assessing the safety of ETC-159 in treating different types of cancers. more info >> |
|
Friday, July 24, 2020 |
|
MP Biomedicals and A*STAR Co-Develop Rapid Antibody Test Kit for SARS-CoV-2 |
MP Biomedicals Asia Pacific Pte Ltd, a diagnostic corporation which has been operating for over 30 years focusing on various infectious disease testing development and manufacturing, today announced the successful development of a rapid antibody test kit for COVID-19, in collaboration with the Agency for Science, Technology and Research (A*STAR). more info >> |
|
Tuesday, October 22, 2019 |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
Fujitsu, SMU and A*STAR Launch Digital Platform Experimentation Project using Quantum-Inspired Computing and Deep Learning Technology |
Fujitsu Limited, the Singapore Management University (SMU) and the Agency for Science, Technology and Research (A*STAR)'s Institute of High Performance Computing today announced the launch of the Digital Platform Experimentation Project. more info >> |
|
Monday, October 21, 2019 |
|
富士通・シンガポール科学技術庁・Singapore Management University、「デジタルアニーラ」とディープラーニング技術を活用したプロジェクトを開始 |
富士通株式会社とシンガポール科学技術庁のハイパフォーマンスコンピューティング研究所(Institute of High Performance Computing)、およびSingapore Management Universityはこのたび、「FUJITSU Quantum-Inspired Computing Digital Annealer」とディープラーニング技術を活用したデジタルプラットフォーム実装プロジェクトを開始します。 more info >> |
|
Friday, June 28, 2019 |
|
Singapore's Drug Development Efforts Given Additional Momentum with National Platforms |
The nation's drug development efforts have been given additional momentum with the introduction of two new platforms, and a grant scheme for drug discovery and development. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
透云生物引领餐饮界新「潮流」 莱茵衣藻获逾百家知名餐饮品牌及米芝莲餐厅入馔
Dec 5, 2023 10:00 HKT/SGT
|
|
|
透雲生物引領餐飲界新「潮流」 萊茵衣藻獲逾百家知名餐飲品牌及米芝蓮餐廳入饌
Dec 5, 2023 09:59 HKT/SGT
|
|
|
Reach Announces Platform-Agnostic Global Tax Compliance Solution
Dec 5, 2023 08:00 HKT/SGT
|
|
|
BluWave-ai and Dubai Taxi Corporation Debut AI Optimization of EV Fleet
Dec 5, 2023 05:00 HKT/SGT
|
|
|
AJ Issenman Joins AELF FlightService as Director of Capital Markets
Dec 4, 2023 23:00 HKT/SGT
|
|
|
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Dec 4, 2023 22:52: JST
|
|
|
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Dec 4, 2023 21:49 HKT/SGT
|
|
|
SolidusMarkets Reports on 'Global Inflation Landscape and Impacts on Asset Classes'
Dec 4, 2023 21:26: JST
|
|
|
Wiz Acquires Raftt, Bolsters CNAPP Offering for Cloud and Kubernetes Developers
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium在2024年首次生產前已獲得充分資金支持
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium在2024年首次生产前已获得充分资金支持
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Atlas Lithium Fully Funded to First Production in 2024
Dec 4, 2023 21:00 HKT/SGT
|
|
|
Q2 Metals Receives Proceeds of $2.0 Million from Shareholder Warrant Exercises
Dec 4, 2023 20:39 HKT/SGT
|
|
|
SolidusMarkets Reports on 'Global Inflation Landscape and Impacts on Asset Classes'
Dec 4, 2023 20:20 HKT/SGT
|
|
|
Pertamina Reaffirms its Commitment to Net Zero Emissions by 2060
Dec 4, 2023 20:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|